Ralaniten acetate

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameRalaniten acetate
Drug Alias NameEPI-506Pro-drug of EPI-002
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionAndrogen Receptor antagonists
TargetsAndrogen Receptor
Therapy Area/IndicationsProstatic DiseasesGenital Diseases, MaleProstatic Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEssa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEssa Pharmaceuticals Corp
Active IndicationsN/A
Inactive IndicationsProstatic DiseasesGenital Diseases, MaleProstatic Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksWikipedia